These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 26644017)

  • 1. Chronotherapy in practice: the perspective of the community pharmacist.
    Kaur G; Gan YL; Phillips CL; Wong K; Saini B
    Int J Clin Pharm; 2016 Feb; 38(1):171-82. PubMed ID: 26644017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Australian community pharmacists' awareness and practice in supporting secondary prevention of cardiovascular disease.
    Puspitasari HP; Aslani P; Krass I
    Int J Clin Pharm; 2013 Dec; 35(6):1218-28. PubMed ID: 24057435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacists' views on Indigenous health: is there more that can be done?
    Stoneman J; Taylor SJ
    Rural Remote Health; 2007; 7(3):743. PubMed ID: 17688377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacists' perspectives about their role in care of patients with diabetes observing Ramadan.
    Almansour HA; Chaar B; Saini B
    Res Social Adm Pharm; 2017; 13(1):109-122. PubMed ID: 27053428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoting weight management services in community pharmacy: perspectives of the pharmacy team in Scotland.
    Weidmann AE; MacLure K; Marshall S; Gray G; Stewart D
    Int J Clin Pharm; 2015 Aug; 37(4):599-606. PubMed ID: 25822039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacists' perceptions and communication of risk for alertness impairing medications.
    Jomaa I; Odisho M; Cheung JMY; Wong K; Ellis JG; Smyth T; Saini B
    Res Social Adm Pharm; 2018 Jan; 14(1):31-45. PubMed ID: 28118967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring pharmacists' views on an in-pharmacy medication review program in Australia using a mixed-methods design.
    Buss VH; Shield A; Kosari S; Peterson GM; Naunton M
    Int J Clin Pharm; 2020 Dec; 42(6):1385-1395. PubMed ID: 32803556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of hypertension in an Australian community pharmacy setting - patients' beliefs and perspectives.
    Bajorek BV; LeMay KS; Magin PJ; Roberts C; Krass I; Armour CL
    Int J Pharm Pract; 2017 Aug; 25(4):263-273. PubMed ID: 27633151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring factors underlying the attitude of community pharmacists to generic substitution: a nationwide study from Poland.
    Drozdowska A; Hermanowski T
    Int J Clin Pharm; 2016 Feb; 38(1):162-70. PubMed ID: 26620450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacists' and consumers' viewpoints on counselling on prescription medicines in Australian community pharmacies.
    Puspitasari HP; Aslani P; Krass I
    Int J Pharm Pract; 2010 Aug; 18(4):202-8. PubMed ID: 20636671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementing oral chemotherapy services in community pharmacies: a qualitative study of chemotherapy nurses' and pharmacists' views.
    Butt F; Ream E
    Int J Pharm Pract; 2016 May; 24(3):149-59. PubMed ID: 26671523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
    Wibowo Y; Parsons R; Sunderland B; Hughes J
    Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A qualitative study exploring perceptions and attitudes of community pharmacists about extended pharmacy services in Lahore, Pakistan.
    Hashmi FK; Hassali MA; Khalid A; Saleem F; Aljadhey H; Babar ZUD; Bashaar M
    BMC Health Serv Res; 2017 Jul; 17(1):500. PubMed ID: 28724411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Independent prescribing by pharmacists: a study of the awareness, views and attitudes of Scottish community pharmacists.
    George J; Pfleger D; McCaig D; Bond C; Stewart D
    Pharm World Sci; 2006 Apr; 28(2):45-53. PubMed ID: 16752193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation screening in pharmacies using an iPhone ECG: a qualitative review of implementation.
    Lowres N; Krass I; Neubeck L; Redfern J; McLachlan AJ; Bennett AA; Freedman SB
    Int J Clin Pharm; 2015 Dec; 37(6):1111-20. PubMed ID: 26202627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hospital pharmacists' and patients' views about what constitutes effective communication between pharmacists and patients.
    Chevalier BAM; Watson BM; Barras MA; Cottrell WN
    Int J Pharm Pract; 2018 Oct; 26(5):450-457. PubMed ID: 29210472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Issues with prescribed medications in Aboriginal communities: Aboriginal health workers' perspectives.
    Hamrosi K; Taylor SJ; Aslani P
    Rural Remote Health; 2006; 6(2):557. PubMed ID: 16683907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mifepristone (RU486) in Australian pharmacies: the ethical and practical challenges.
    Lee RY; Moles R; Chaar B
    Contraception; 2015 Jan; 91(1):25-30. PubMed ID: 25248673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular disease risk screening by pharmacists: a behavior change wheel guided qualitative analysis.
    Almansour HA; Mekonnen AB; Aloudah NM; Alhawassi TM; Mc Namara K; Chaar B; Krass I; Saini B
    Res Social Adm Pharm; 2020 Feb; 16(2):149-159. PubMed ID: 31027964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated primary care insomnia management in Australia.
    Sake FT; Wong K; Bartlett DJ; Saini B
    Res Social Adm Pharm; 2018 Feb; 14(2):170-179. PubMed ID: 28262515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.